BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2502041)

  • 1. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
    Ordosgoitia H; Castro C; Carbayeda M; Labella T
    An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of pharmacological treatment in the compensation of vertigo].
    Pons Rocher F
    An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and therapeutic experience in 151 consecutive protocolized cases with vertigo syndrome of cervical origin. Comparative study of a cinnarizine and dihydroergocristine combination with a cinnarizine and dihydroergocristine plus anti-inflammatory agents combination].
    Bartual J; Vidal J; Magro E; Roquette J
    Acta Otorrinolaringol Esp; 1988; 39(5):331-8. PubMed ID: 3152492
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
    Oswald WD; Matejcek M; Lukaschek K; Dennler HJ; Oswald B
    Arzneimittelforschung; 1982; 32(5):584-90. PubMed ID: 7201839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of piracetam in vertigo.
    Fernandes CM; Samuel J
    S Afr Med J; 1985 Nov; 68(11):806-8. PubMed ID: 4071329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of vertigo syndrome with Nootropil].
    Miszke A; Rapacz K
    Otolaryngol Pol; 1988; 42(5):312-7. PubMed ID: 3075732
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic trial of nootropyl in otorhinolaryngology].
    Ammar-Khodja A
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(9-10):697-700. PubMed ID: 4462173
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the dose-effect relationship in the therapy with piracetam (author's transl)].
    Kretschmar JH; Kretschmar CH
    Arzneimittelforschung; 1976; 26(6):1158-9. PubMed ID: 786310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium].
    Ulbricht B
    Med Welt; 1976 Oct; 27(40):1912-5. PubMed ID: 790079
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of minocycline-induced brainstem vertigo by the combined administration of piracetam and ergotoxin.
    Claussen CF; Schneider D; Patil NP
    Acta Otolaryngol Suppl; 1989; 468():171-4. PubMed ID: 2635498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of piracetam in the treatment of sudden idiopathic deafness. Preliminary report].
    Gersdorff M; Franceschi D
    Ann Otolaryngol Chir Cervicofac; 1986; 103(4):283-5. PubMed ID: 3777763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled clinical trial on the effect of piracetam in epileptic children.
    Kunneke PS; Malan GM
    Br J Clin Pract; 1979 Sep; 33(9):266-71. PubMed ID: 385029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Minimal brain dysfunction. III. Treatment (preliminary report)].
    Rafael Cruz H; Valadez MT
    Salud Publica Mex; 1987; 29(1):55-60. PubMed ID: 2885925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.